Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
about
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cellsCMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathwayData mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.Steatosis and steatohepatitis: complex disorders.Retinoid pathway and cancer therapeuticsChIP-seq in steatohepatitis and normal liver tissue identifies candidate disease mechanisms related to progression to cancer.Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study.Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatmentProtective Effect of Hericium erinaceus on Alcohol Induced Hepatotoxicity in Mice.Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ AgonistOxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence.Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced SteatohepatitisThe burden of cancer attributable to alcohol consumptionPreservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in ratsA novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1)The interaction between HCV and nuclear receptor-mediated pathwaysAlcohol and Cancer: Mechanisms and Therapies.Alcohol extract of North American ginseng (Panax quinquefolius) reduces fatty liver, dyslipidemia, and other complications of metabolic syndrome in a mouse model.22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα.TLR4 signaling and the inhibition of liver hepcidin expression by alcohol.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.Dietary nicotinic acid supplementation ameliorates chronic alcohol-induced fatty liver in rats.Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice.Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.Association between expression of nuclear receptor co-activator 5 protein and prognosis in postoperative patients with osteosarcoma.
P2860
Q26769611-45F8AEE7-BBD6-4F1D-B514-A59508F978C0Q27303175-6743618C-F60D-41FB-AC53-AABD5F26A039Q28539316-159E858C-4661-4FCA-BF31-318E8CFEC3ADQ33875631-0514FA2C-5B71-4B2E-898F-7C8FE829AFE8Q33907632-8CD95A15-36A6-4A5D-B942-723340A230A6Q34348117-292148DF-0B24-464D-9CC3-186FC5215B41Q35037365-F9BECAFC-B874-4067-BE22-142E6F31B044Q35380194-F010D457-4A0E-48AF-BC93-27386F326CACQ35527928-53FD502C-E654-4633-B27F-2332CCFF9D0AQ35557543-4457CB0C-AABD-4F58-A53A-6238125C65E9Q35592839-D6111341-49B0-4865-B566-0988037BADEAQ35674852-41959691-D490-4469-B085-6B34464526A4Q35816465-DA941617-D3E6-47EF-B158-10F092B1D071Q36011202-C1365ABF-51CB-467C-B520-98DC88BD9F04Q36082622-2D188CFD-4CDB-41AD-BC53-FA054024669AQ36745656-04AB4C24-D3D6-44A9-BF9C-4F3A03678D62Q36873586-20260E20-B48D-4A2C-A6C8-F5ECEB475C73Q37881205-73AD99C1-8C13-4894-90FB-E62321109F2FQ38642925-C9C9F6C3-8BBB-4A90-A8B5-6254277C5CEAQ38699935-7300DAA8-FFEF-42E2-BBA0-15118BB7C5D0Q41564669-C44A1901-8B70-4FF4-9A97-537793D1DCD3Q41847903-A5613EAC-8BD3-44AE-9446-B86E8CD83817Q42367659-E9A6B429-E8F8-4B94-A007-473922BBEE8BQ43867191-34169F75-447E-4D17-8877-4561894F8D6FQ47138391-4ACCC8EA-69A4-4174-ADF0-274DB6F876B4Q47419101-18B11A70-3727-498A-8AA7-1BDB772894FEQ50038674-A4B51576-2FF8-4DE2-B6AC-05E43CBE5C9DQ50053701-B46A9656-5466-4425-B88E-CEB8CE7153FA
P2860
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@en
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@nl
type
label
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@en
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@nl
prefLabel
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@en
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@nl
P2860
P356
P1476
Pathogenesis of alcoholic liver disease: the role of nuclear receptors.
@en
P2093
Maxwell Afari Gyamfi
Yu-Jui Yvonne Wan
P2860
P304
P356
10.1258/EBM.2009.009249
P577
2010-05-01T00:00:00Z